首页> 外文会议>15th World Congress on Breast Disease and 3rd Shanghai Breast Cancer Symposium(第十五届国际乳腺病大会暨第三届上海国际乳腺癌论坛) >Protection From High Dose Chemotherapy By Transduced With Double-Mutant Dihydrofolate Reductase-Cytidine Deaminase Genes Into Mice bone marrow cells
【24h】

Protection From High Dose Chemotherapy By Transduced With Double-Mutant Dihydrofolate Reductase-Cytidine Deaminase Genes Into Mice bone marrow cells

机译:通过双重突变的二氢叶酸还原酶-胞苷脱氨酶基因转导进入小鼠骨髓细胞来预防大剂量化疗

获取原文
获取原文并翻译 | 示例

摘要

Background and Aim:Drug resistance gene (genes) transfer could increase the tolerance of bone marrow cell to chemotherapeutic agents. We transferred fusion drug resistance genes of DHFR gene and CD gene into mouse bone marrow cells to explore the feasibility of the tolerance of myelosuppression following combination chemotherapy and improve the clinical efficiency. The protection of bone marrow with the genes would allow larger and curative doses of high dose MTX and Ara-C.
机译:背景与目的:耐药基因(基因)的转移可增加骨髓细胞对化疗药物的耐受性。我们将DHFR基因和CD基因的融合耐药基因转移到小鼠骨髓细胞中,以探讨联合化疗后耐受骨髓抑制的可行性并提高临床效率。该基因对骨髓的保护将允许更大剂量的治愈性大剂量MTX和Ara-C。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号